Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Bullboard Posts
Comment by BearDownAZon Apr 25, 2013 1:03pm
212 Views
Post# 21300930

RE: RE: RE: RE: More from Esperion

RE: RE: RE: RE: More from Esperion

It's all about risk factors.

 

LDL is the primary lipoprotein that is taken up by the cells that end up causing atherosclerosis. In general, the more LDL in the blood, the higher the risk for atherosclerosis. However, it's more complex than that because LDL exists in several different sizes. Certain metabolic conditions (such as insulin resistance, diabetes, fatty liver) give rise to a great amount of the more atherogenic small LDL particles.

 

HDL as we all know does the RCT process. ANd HDL levels are inversely correlated with risk for atherosclerosis. So it is a balance between these two processes. I don't think anyone could factually state at this point in time that one is more important than the other. But if someone does have higher than normal LDL-cholesterol, it is advisable to get that under control.

Bullboard Posts